School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Sweden.
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
JNCI Cancer Spectr. 2024 Apr 30;8(3). doi: 10.1093/jncics/pkae043.
Socioeconomic inequalities in the uptake of colorectal cancer screening are well documented, but the implications on inequities in health gain remain unclear.
Sixty-year-olds were randomly recruited from the Swedish population between March 2014 and March 2020 and invited to undergo either 2 rounds of fecal immunochemical testing (FIT) 2 years apart (n = 60 137) or primary colonoscopy just once (n = 30 400). By linkage to Statistics Sweden's registries, we obtained socioeconomic data. In each defined socioeconomic group, we estimated the cumulative yield of advanced neoplasia in each screening arm (intention-to-screen analysis). In the biennial FIT arm, we predicted the probability of exceeding the yield in the primary colonoscopy arm by linear extrapolation of the cumulative yield to (hypothetical) additional rounds of FIT.
In the lowest income group, the yield of advanced neoplasia was 1.63% (95% confidence interval [CI] = 1.35% to 1.93%) after 2 rounds of FIT vs 1.93% (95% CI = 1.49% to 2.40%) in the primary colonoscopy arm. Extrapolation to a third round of FIT implied a 86% probability of exceeding the yield in the primary colonoscopy arm. In the highest income group, we found a more pronounced yield gap between the 2 screening strategies-2.32% (95% CI = 2.15% to 2.49%) vs 3.71% (95% CI = 3.41% to 4.02%)- implying a low (2%) predicted probability of exceeding yield after a third round of FIT.
Yield of advanced neoplasia from 2 rounds of FIT 2 years apart was poorer as compared with primary colonoscopy, but the difference was less in lower socioeconomic groups.
ClinicalTrials.gov identifier NCT02078804.
社会经济不平等在结直肠癌筛查的参与度方面已有充分记录,但对健康收益不平等的影响仍不清楚。
2014 年 3 月至 2020 年 3 月期间,从瑞典人群中随机招募 60 岁人群,并邀请他们接受 2 轮粪便免疫化学检测(FIT),每 2 年进行一次(n=60137)或仅进行一次结肠镜检查(n=30400)。通过与瑞典统计局的登记册相联系,我们获得了社会经济数据。在每个定义的社会经济群体中,我们估计了每个筛查臂的高级别肿瘤的累积检出率(意向筛查分析)。在每两年进行一次的 FIT 臂中,我们通过线性外推累积检出率来预测在结肠镜检查臂中超过检出率的概率(假设)额外轮次的 FIT。
在收入最低的群体中,两轮 FIT 后的高级别肿瘤检出率为 1.63%(95%置信区间[CI]为 1.35%至 1.93%),而结肠镜检查臂中的检出率为 1.93%(95%CI为 1.49%至 2.40%)。外推到第三轮 FIT 意味着超过结肠镜检查臂检出率的概率为 86%。在收入最高的群体中,我们发现两种筛查策略之间的检出率差距更大-2.32%(95%CI为 2.15%至 2.49%)比 3.71%(95%CI为 3.41%至 4.02%)-这意味着第三轮 FIT 后,预计检出率的概率很低(2%)。
两年进行两轮 FIT 的高级别肿瘤检出率不如结肠镜检查,但在较低的社会经济群体中差异较小。
ClinicalTrials.gov 标识符 NCT02078804。